Subscribe to Newsletter
Techniques & Tools Mass Spectrometry, Clinical, Proteomics

Deadly Burn Biomarkers

Despite the high incidence of severe burns, the subsequent processes are complex and not fully understood. “Burns are known to cause severe circulatory, immune, metabolic, and coagulation system dysregulation. For example, right after an injury, there is an immediate increase in capillary permeability, which is one of the main factors leading to circulatory failure. However, the details behind many of these mechanisms are still unclear,” said Shinya Onishi (1), lead author of a study from Osaka University that sheds new light on the subject (2).

By applying an MS-based proteomics approach to the plasma of 10 healthy volunteers and 83 burn patients – 15 of which died within a 28-day period – the team was able to identify 10 proteins that were linked to mortality after statistical analysis. Three of those proteins (HBA1, TTR, and SERPINF2) showed the highest association with mortality and were then used by the researchers to classify patients into three clinical phenotypes.

HBA1 is a hemoglobin subunit that is associated with hemolysis, TTR is an indicator of the breakdown of proteins in the body, and SERPINF2 is associated with the development and dissolution of blood clots. The group with the highest mortality had higher levels of HBA1 and lower levels of TTR and SERPINF2 compared with other groups. 

“These three proteins can function as important prognostic biomarkers for burn patients,” said Onishi. But the authors also highlighted the possibility of exploring the mortality-linked proteins for therapeutic development. Indeed, Jun Oda, another senior author on the study, noted that, in addition to better understanding the pathogenesis of life-threatening burns, a clear goal of the work is to explore “novel molecular pathways in burn victims that might be the targets of future drugs.”

Credit: Bandaged hand by Guitarfoto from Shutterstock.com, adapted In House

Receive content, products, events as well as relevant industry updates from The Analytical Scientist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

  1. ResOU (2023). Available at https://bit.ly/3KvHBZ0
  2. S Onishi et al., iScience, 26, (2023). DOI: 10.1016/j.isci.2023.107271
About the Author
Markella Loi

Associate Editor, The Analytical Scientist

Related Application Notes
Charge heterogeneity characterisation of an IgG4-based mAb using AEX coupled to MS

| Contributed by YMC

Uncover Epimers in Natural Extract Analysis

| Contributed by MOBILion Systems Inc

Expand Your PFAS Analysis. Screen for Targets and Identify Unknowns Simultaneously

| Contributed by Leco

Related Product Profiles
Higher Peaks – Clearly.

| Contributed by Shimadzu Europa

Compact with countless benefits

| Contributed by Shimadzu Europa

The fine Art of Method Development

| Contributed by Shimadzu Europa

Most Popular
Register to The Analytical Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Analytical Scientist magazine

Register